Cardiovascular Diseases (CVDs) are the leading cause of death worldwide with an estimated 18M fatalities annually and covering 30% of all fatalities on a global scale. The most common CVDs include coronary heart disease, cerebrovascular disease, and rheumatic heart disease.
MUNICH, GERMANY. Jun 28, 2022. Startup Creasphere welcomed leading healthcare partners, VC investors, like-minded startup founders, and many more healthcare stakeholders to EXPO 8.
The pursuit of achieving personalized treatment possibilities and optimized health outcomes at scale is one of the key driving forces that will also continue to be explored in 2022. A central framework to foster greater healthcare individualization can be found in the Digital Twin technology.
Computers are more indispensable in our daily lives than ever before. They influence how we live in both obvious and non obvious ways. The next obvious development step in human machine interaction is an interface which enables a more frictionless communication.
MUNICH, GERMANY. Feb 03, 2022. Startup Creasphere celebrates EXPO 7 showcasing 7 successful pilot projects between the corporate partners Roche and BIOTRONIK and Batch 7 startups.
In light of the World Cancer Day today, we want to take the special opportunity to raise increased awareness and ongoing support to the disease area of cancer and the great patient community involved.
We are excited to announce some investment news around two of our current Batch 7 startups, Labelbox and Tag-N-Trac, as well as an alumni from Batch 1 - Infermedica.
Type 2 Diabetes has traditionally been considered to be a lifelong condition where one can only hope for better blood sugar control. But modern-age diabetes care and treatment is challenging this long held belief, especially for those who are newly diagnosed with diabetes.
In 2021, Plug and Play Munich has invested into four disruptive and promising healthcare startups in the fields of Digital Twin for Medical Device Development, Digital Biomarker Respiratory Diseases, Clinical Workflow Optimization and Digital Biomarker for Eye Health.
Menopause is a natural biological process that marks the cessation of the female menstrual cycle, typically occurring for the majority of women in their late 40s and early 50s. In order to lower the severity of symptoms commonly associated with Menopause, digital solutions provide an
